Universe · entity
ARCH Venture Management, LLC
Institutional manager (13F) · CIK 1274403
13F holdings · as of 2026-03-31 · top 10 · reported portfolio $677M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | MAZE THERAPEUTICS INC | $123M | 4,120,053 |
| 2 | RAPPORT THERAPEUTICS INC | $117M | 3,728,738 |
| 3 | VIR BIOTECHNOLOGY INC | $116M | 12,916,663 |
| 4 | ERASCA INC | $115M | 7,091,557 |
| 5 | BEAM THERAPEUTICS INC | $108M | 4,540,132 |
| 6 | LYELL IMMUNOPHARMA INC | $65M | 3,247,162 |
| 7 | GENERATE BIOMEDICINES INC | $24M | 1,944,426 |
| 8 | 10X GENOMICS INC | $5M | 217,834 |
| 9 | GOSSAMER BIO INC | $3M | 8,055,916 |
| 10 | Q32 BIO INC | $2M | 320,482 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.